Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Pernot

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 19, 2024
Impact on survival without chemotherapy of local treatments of lung metastasis of colorectal cancers: Analysis on REPULCO cohortLola-Jade Palmieri, Yaniss Belaroussi, Noémie Huchet, et al.
Oncogene|July 12, 2026
Furin sustains tumor-promoting signals in KRAS- and BRAF-mutated colorectal cancer by engaging the TGF-β1-COX-2 axis in a reciprocal regulatory networkYiyang Liu, Géraldine Siegfried, Simon Pernot, et al.
British Journal of Cancer|July 21, 2018
Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with menSimon Pernot, Pauline Boucheron, Hélène Péré, et al.
British Journal of Cancer|March 27, 2019
Comment on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis"Hélène Péré, Juliette Pavie, Simon Pernot, et al.
Cancers|March 10, 2022
Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon TumorsJean Descarpentrie, Marcos J Araúzo-Bravo, Zongsheng He, et al.
Clinics and Research in Hepatology and Gastroenterology|March 31, 2021
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH surveyDebora Basile, Claire Gallois, Fabio Puglisi, et al.
Frontiers in Medicine|July 5, 2022
Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal CancerViolaine Randrian, Simon Pernot, Baptiste Sionneau, et al.
International Journal of Cancer|September 1, 2019
Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancerEmilie Moati, Hélène Blons, Valerie Taly, et al.
Clinical Colorectal Cancer|October 26, 2019
Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter StudyMarie Auvray, David Tougeron, Edouard Auclin, et al.
British Journal of Cancer|February 12, 2022
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 19, 2024
Impact on survival without chemotherapy of local treatments of lung metastasis of colorectal cancers: Analysis on REPULCO cohortLola-Jade Palmieri, Yaniss Belaroussi, Noémie Huchet, et al.
Oncogene|July 12, 2026
Furin sustains tumor-promoting signals in KRAS- and BRAF-mutated colorectal cancer by engaging the TGF-β1-COX-2 axis in a reciprocal regulatory networkYiyang Liu, Géraldine Siegfried, Simon Pernot, et al.
British Journal of Cancer|July 21, 2018
Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with menSimon Pernot, Pauline Boucheron, Hélène Péré, et al.
British Journal of Cancer|March 27, 2019
Comment on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis"Hélène Péré, Juliette Pavie, Simon Pernot, et al.
Cancers|March 10, 2022
Role of Furin in Colon Cancer Stem Cells Malignant Phenotype and Expression of LGR5 and NANOG in KRAS and BRAF-Mutated Colon TumorsJean Descarpentrie, Marcos J Araúzo-Bravo, Zongsheng He, et al.
Clinics and Research in Hepatology and Gastroenterology|March 31, 2021
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH surveyDebora Basile, Claire Gallois, Fabio Puglisi, et al.
Frontiers in Medicine|July 5, 2022
Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal CancerViolaine Randrian, Simon Pernot, Baptiste Sionneau, et al.
International Journal of Cancer|September 1, 2019
Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancerEmilie Moati, Hélène Blons, Valerie Taly, et al.
Clinical Colorectal Cancer|October 26, 2019
Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter StudyMarie Auvray, David Tougeron, Edouard Auclin, et al.
British Journal of Cancer|February 12, 2022
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
Pageof 11